Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease

Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease

BACKGROUND: In Switzerland, the first course of intravenous steroids for treatment of episodes of demyelinating CNS disease is usually administered in an inpatient setting. We prospectively evaluated short term tolerance of treatment with special emphasis on sleep quality. METHODS:...

Full description

Bibliographic Details
Main Authors: Carmen Lienert, Gabriela Schawalder, Oliver Findling, Christian P Kamm, Sebastian Humpert, Anne Mugglin, Johannes Mathis, Mathias Sturzenegger, Heinrich P Mattle
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2013-05-01
Series:Swiss Medical Weekly
Subjects:
intravenous steroid treatment
Multiple sclerosis
sleep/activity pattern
Online Access:https://www.smw.ch/index.php/smw/article/view/1689

Internet

https://www.smw.ch/index.php/smw/article/view/1689

Similar Items